BioRem ( CVE:BRM ) Third Quarter 2024 Results Key Financial Results Revenue: CA$14.9m (up 170% from 3Q 2023). Net...
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2024. BIOREM's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).